Lam Karen C 4
4 · RAPT Therapeutics, Inc. · Filed May 8, 2020
Insider Transaction Report
Form 4
Lam Karen C
VP, Finance & Controller
Transactions
- Sale
Common Stock
2020-05-07$15.40/sh−1,831$28,197→ 10,833 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on April 27, 2020.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.135 to $15.74, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F3]Includes 1,831 shares acquired by the reporting person under the Issuer's 2019 Employee Stock Purchase Plan on May 1, 2020.